查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1867535

细胞库外包：全球市场占有率和排名、总收入和需求预测（2025-2031年）

Cell Banking Outsourcing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 136 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024 年全球细胞库外包市场规模估计为 93.72 亿美元，预计到 2031 年将达到 264.85 亿美元，在预测期（2025-2031 年）内复合年增长率为 16.1%。

细胞库外包是指将细胞样本（例如干细胞、免疫细胞和基因工程细胞）的采集、处理、扩增和储存等关键流程外包给专业的第三方服务供应商。这些服务包括符合GMP标准的标准化生物银行流程、严格的品管以及贯穿整个生命週期的资料可追溯性。随着精准医疗、细胞疗法和生物製药研发的快速发展，细胞库外包正成为全球医疗保健和生命科学产业的重要基础设施，弥合了临床研究与商业应用之间的鸿沟。

全球生物製药产业正经历结构性转型，细胞和基因疗法等新兴治疗方法推动了对大规模、高品质细胞样本库需求的激增。为了提高效率并减轻营运负担，生技公司越来越多地采用轻资产研发模式，将细胞库建置、品管(QC) 和储存作业外包给拥有 GMP 或 ISO 认证的专业供应商。同时，中国、美国、韩国和新加坡等国的国家政策继续将细胞库建设作为战略基础设施发展的重点。这些因素共同推动了细胞库外包市场的快速成长，并作为关键基础设施服务吸引了资本和产业的注意。然而，儘管需求强劲，该产业仍面临许多挑战。全球监管差异，尤其是在跨境检体转移、伦理审查和资料主权等领域，造成了合规的复杂性。该行业的准入门槛很高，需要对基础设施、合格人员和品质系统进行大量投资。客户对资料完整性、生物安全性和长期储存可靠性的期望不断提高，也推动了市场整合。因此，大型供应商正在巩固其市场地位，而小型企业则面临日益增长的营运和竞争压力。市场需求正从早期学术和研究应用转向后期和商业性临床项目，尤其是CAR-T疗法、基于iPS细胞的再生医学和个人化免疫疗法。 III期及以上阶段的试验需要更严格的样本处理和储存通讯协定。此外，全球製药公司和CRO/CMO正在重组其供应链，推动采用多点采集、区域生物银行和即时数位追溯系统。在这个快速成熟的市场环境中，提供整合化、自动化且完全合规服务的供应商将获得优势，并成为以平台为中心、主要企业。

本报告旨在按地区/国家、类型和应用对全球细胞库外包市场进行全面分析，重点关注总收入、市场份额和主要企业的排名。

本报告以收益为准，以2024年为基准年，对细胞库外包市场规模、估算和预测进行了分析，并包含了2020年至2031年的历史数据和预测数据。报告采用定量和定性分析相结合的方法，帮助读者制定业务/成长策略，评估市场竞争格局，分析自身在当前市场中的地位，并就细胞库外包业务做出明智的决策。

市场区隔

公司

  • SGS Life Sciences
  • Lonza
  • CCBC
  • Vcanbio
  • AMAG Pharmaceuticals
  • ViaCord
  • Thermo Fisher
  • Wuxi Apptec
  • CordLife
  • Esperite
  • Reliance Life Sciences
  • Lifecell
  • Cryo-Cell
  • Toxikon
  • Goodwin Biotechnology
  • Texcell
  • Cryo Stemcell

按类型分類的细分市场

  • 干细胞库
  • 非干细胞库

应用领域

  • 细胞库储存
  • 银行特征分析与测试
  • 细胞库製备

按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 东南亚
    • 印度
    • 澳洲
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 荷兰
    • 北欧国家
    • 其他欧洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

The global market for Cell Banking Outsourcing was estimated to be worth US$ 9372 million in 2024 and is forecast to a readjusted size of US$ 26485 million by 2031 with a CAGR of 16.1% during the forecast period 2025-2031.

Cell Banking Outsourcing refers to the practice of delegating the critical processes of collecting, processing, expanding, and storing cell samples-such as stem cells, immune cells, or genetically engineered cells-to specialized third-party service providers. This service involves standardized GMP-compliant biobanking procedures, stringent quality control, and full lifecycle data traceability. With the rapid expansion of precision medicine, cell therapies, and biopharmaceutical R&D, outsourced cell banking is becoming a vital infrastructure across the global healthcare and life sciences industries, bridging the gap from clinical research to commercial application.

The global biopharmaceutical sector is undergoing structural transformation, with emerging therapies such as cell and gene therapy driving a surge in demand for large-scale, high-quality cell sample banking. Biotech companies are increasingly favoring asset-light R&D models, outsourcing cell banking, QC, and storage to specialized providers with GMP or ISO certifications to enhance efficiency and reduce operational burden. Meanwhile, national policies in countries like China, the U.S., South Korea, and Singapore continue to prioritize cell banking as a strategic infrastructure initiative. These factors jointly propel the Cell Banking Outsourcing market into a high-growth trajectory, attracting both capital and industry attention as a critical enabling service. Despite strong demand, the sector faces considerable hurdles. Global disparities in regulation-especially in areas such as sample cross-border transfer, ethical approvals, and data sovereignty-present compliance complexities. The industry has high entry barriers, requiring significant investment in infrastructure, certified personnel, and quality systems. Client expectations around data integrity, biosafety, and long-term storage reliability are also rising, leading to market consolidation. As a result, while leading providers strengthen their positions, smaller players face increasing operational and competitive pressures.Demand is shifting from early-stage academic and research applications to late-phase and commercial clinical programs, especially in CAR-T, iPSC-based regenerative therapies, and personalized immunotherapies. Phase III+ trials require stricter sample handling and storage protocols. Additionally, global pharma and CRO/CMO players are reshaping their supply chains, driving the adoption of multi-site collection, regionalized biobanking, and real-time digital traceability systems. The future will favor providers offering integrated, automated, and fully compliant services-emerging as platform-centric and ecosystem-leading companies in a rapidly maturing landscape.

This report aims to provide a comprehensive presentation of the global market for Cell Banking Outsourcing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Cell Banking Outsourcing by region & country, by Type, and by Application.

The Cell Banking Outsourcing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell Banking Outsourcing.

Market Segmentation

By Company

  • SGS Life Sciences
  • Lonza
  • CCBC
  • Vcanbio
  • AMAG Pharmaceuticals
  • ViaCord
  • Thermo Fisher
  • Wuxi Apptec
  • CordLife
  • Esperite
  • Reliance Life Sciences
  • Lifecell
  • Cryo-Cell
  • Toxikon
  • Goodwin Biotechnology
  • Texcell
  • Cryo Stemcell

Segment by Type

  • Stem Cell Banking
  • Non-stem Cell Banking

Segment by Application

  • Cell Bank Storage
  • Bank Characterization and Testing
  • Cell Bank Preparation

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Cell Banking Outsourcing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Cell Banking Outsourcing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Cell Banking Outsourcing in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Cell Banking Outsourcing Product Introduction
  • 1.2 Global Cell Banking Outsourcing Market Size Forecast (2020-2031)
  • 1.3 Cell Banking Outsourcing Market Trends & Drivers
    • 1.3.1 Cell Banking Outsourcing Industry Trends
    • 1.3.2 Cell Banking Outsourcing Market Drivers & Opportunity
    • 1.3.3 Cell Banking Outsourcing Market Challenges
    • 1.3.4 Cell Banking Outsourcing Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Cell Banking Outsourcing Players Revenue Ranking (2024)
  • 2.2 Global Cell Banking Outsourcing Revenue by Company (2020-2025)
  • 2.3 Key Companies Cell Banking Outsourcing Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Cell Banking Outsourcing Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of Cell Banking Outsourcing
  • 2.6 Cell Banking Outsourcing Market Competitive Analysis
    • 2.6.1 Cell Banking Outsourcing Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by Cell Banking Outsourcing Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Banking Outsourcing as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Stem Cell Banking
    • 3.1.2 Non-stem Cell Banking
  • 3.2 Global Cell Banking Outsourcing Sales Value by Type
    • 3.2.1 Global Cell Banking Outsourcing Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Cell Banking Outsourcing Sales Value, by Type (2020-2031)
    • 3.2.3 Global Cell Banking Outsourcing Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Cell Bank Storage
    • 4.1.2 Bank Characterization and Testing
    • 4.1.3 Cell Bank Preparation
  • 4.2 Global Cell Banking Outsourcing Sales Value by Application
    • 4.2.1 Global Cell Banking Outsourcing Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Cell Banking Outsourcing Sales Value, by Application (2020-2031)
    • 4.2.3 Global Cell Banking Outsourcing Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global Cell Banking Outsourcing Sales Value by Region
    • 5.1.1 Global Cell Banking Outsourcing Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Cell Banking Outsourcing Sales Value by Region (2020-2025)
    • 5.1.3 Global Cell Banking Outsourcing Sales Value by Region (2026-2031)
    • 5.1.4 Global Cell Banking Outsourcing Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America Cell Banking Outsourcing Sales Value, 2020-2031
    • 5.2.2 North America Cell Banking Outsourcing Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe Cell Banking Outsourcing Sales Value, 2020-2031
    • 5.3.2 Europe Cell Banking Outsourcing Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Cell Banking Outsourcing Sales Value, 2020-2031
    • 5.4.2 Asia Pacific Cell Banking Outsourcing Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America Cell Banking Outsourcing Sales Value, 2020-2031
    • 5.5.2 South America Cell Banking Outsourcing Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa Cell Banking Outsourcing Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa Cell Banking Outsourcing Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Cell Banking Outsourcing Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Cell Banking Outsourcing Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Cell Banking Outsourcing Sales Value, 2020-2031
    • 6.3.2 United States Cell Banking Outsourcing Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Cell Banking Outsourcing Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Cell Banking Outsourcing Sales Value, 2020-2031
    • 6.4.2 Europe Cell Banking Outsourcing Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Cell Banking Outsourcing Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Cell Banking Outsourcing Sales Value, 2020-2031
    • 6.5.2 China Cell Banking Outsourcing Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Cell Banking Outsourcing Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Cell Banking Outsourcing Sales Value, 2020-2031
    • 6.6.2 Japan Cell Banking Outsourcing Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Cell Banking Outsourcing Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Cell Banking Outsourcing Sales Value, 2020-2031
    • 6.7.2 South Korea Cell Banking Outsourcing Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Cell Banking Outsourcing Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Cell Banking Outsourcing Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Cell Banking Outsourcing Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Cell Banking Outsourcing Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Cell Banking Outsourcing Sales Value, 2020-2031
    • 6.9.2 India Cell Banking Outsourcing Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Cell Banking Outsourcing Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 SGS Life Sciences
    • 7.1.1 SGS Life Sciences Profile
    • 7.1.2 SGS Life Sciences Main Business
    • 7.1.3 SGS Life Sciences Cell Banking Outsourcing Products, Services and Solutions
    • 7.1.4 SGS Life Sciences Cell Banking Outsourcing Revenue (US$ Million) & (2020-2025)
    • 7.1.5 SGS Life Sciences Recent Developments
  • 7.2 Lonza
    • 7.2.1 Lonza Profile
    • 7.2.2 Lonza Main Business
    • 7.2.3 Lonza Cell Banking Outsourcing Products, Services and Solutions
    • 7.2.4 Lonza Cell Banking Outsourcing Revenue (US$ Million) & (2020-2025)
    • 7.2.5 Lonza Recent Developments
  • 7.3 CCBC
    • 7.3.1 CCBC Profile
    • 7.3.2 CCBC Main Business
    • 7.3.3 CCBC Cell Banking Outsourcing Products, Services and Solutions
    • 7.3.4 CCBC Cell Banking Outsourcing Revenue (US$ Million) & (2020-2025)
    • 7.3.5 CCBC Recent Developments
  • 7.4 Vcanbio
    • 7.4.1 Vcanbio Profile
    • 7.4.2 Vcanbio Main Business
    • 7.4.3 Vcanbio Cell Banking Outsourcing Products, Services and Solutions
    • 7.4.4 Vcanbio Cell Banking Outsourcing Revenue (US$ Million) & (2020-2025)
    • 7.4.5 Vcanbio Recent Developments
  • 7.5 AMAG Pharmaceuticals
    • 7.5.1 AMAG Pharmaceuticals Profile
    • 7.5.2 AMAG Pharmaceuticals Main Business
    • 7.5.3 AMAG Pharmaceuticals Cell Banking Outsourcing Products, Services and Solutions
    • 7.5.4 AMAG Pharmaceuticals Cell Banking Outsourcing Revenue (US$ Million) & (2020-2025)
    • 7.5.5 AMAG Pharmaceuticals Recent Developments
  • 7.6 ViaCord
    • 7.6.1 ViaCord Profile
    • 7.6.2 ViaCord Main Business
    • 7.6.3 ViaCord Cell Banking Outsourcing Products, Services and Solutions
    • 7.6.4 ViaCord Cell Banking Outsourcing Revenue (US$ Million) & (2020-2025)
    • 7.6.5 ViaCord Recent Developments
  • 7.7 Thermo Fisher
    • 7.7.1 Thermo Fisher Profile
    • 7.7.2 Thermo Fisher Main Business
    • 7.7.3 Thermo Fisher Cell Banking Outsourcing Products, Services and Solutions
    • 7.7.4 Thermo Fisher Cell Banking Outsourcing Revenue (US$ Million) & (2020-2025)
    • 7.7.5 Thermo Fisher Recent Developments
  • 7.8 Wuxi Apptec
    • 7.8.1 Wuxi Apptec Profile
    • 7.8.2 Wuxi Apptec Main Business
    • 7.8.3 Wuxi Apptec Cell Banking Outsourcing Products, Services and Solutions
    • 7.8.4 Wuxi Apptec Cell Banking Outsourcing Revenue (US$ Million) & (2020-2025)
    • 7.8.5 Wuxi Apptec Recent Developments
  • 7.9 CordLife
    • 7.9.1 CordLife Profile
    • 7.9.2 CordLife Main Business
    • 7.9.3 CordLife Cell Banking Outsourcing Products, Services and Solutions
    • 7.9.4 CordLife Cell Banking Outsourcing Revenue (US$ Million) & (2020-2025)
    • 7.9.5 CordLife Recent Developments
  • 7.10 Esperite
    • 7.10.1 Esperite Profile
    • 7.10.2 Esperite Main Business
    • 7.10.3 Esperite Cell Banking Outsourcing Products, Services and Solutions
    • 7.10.4 Esperite Cell Banking Outsourcing Revenue (US$ Million) & (2020-2025)
    • 7.10.5 Esperite Recent Developments
  • 7.11 Reliance Life Sciences
    • 7.11.1 Reliance Life Sciences Profile
    • 7.11.2 Reliance Life Sciences Main Business
    • 7.11.3 Reliance Life Sciences Cell Banking Outsourcing Products, Services and Solutions
    • 7.11.4 Reliance Life Sciences Cell Banking Outsourcing Revenue (US$ Million) & (2020-2025)
    • 7.11.5 Reliance Life Sciences Recent Developments
  • 7.12 Lifecell
    • 7.12.1 Lifecell Profile
    • 7.12.2 Lifecell Main Business
    • 7.12.3 Lifecell Cell Banking Outsourcing Products, Services and Solutions
    • 7.12.4 Lifecell Cell Banking Outsourcing Revenue (US$ Million) & (2020-2025)
    • 7.12.5 Lifecell Recent Developments
  • 7.13 Cryo-Cell
    • 7.13.1 Cryo-Cell Profile
    • 7.13.2 Cryo-Cell Main Business
    • 7.13.3 Cryo-Cell Cell Banking Outsourcing Products, Services and Solutions
    • 7.13.4 Cryo-Cell Cell Banking Outsourcing Revenue (US$ Million) & (2020-2025)
    • 7.13.5 Cryo-Cell Recent Developments
  • 7.14 Toxikon
    • 7.14.1 Toxikon Profile
    • 7.14.2 Toxikon Main Business
    • 7.14.3 Toxikon Cell Banking Outsourcing Products, Services and Solutions
    • 7.14.4 Toxikon Cell Banking Outsourcing Revenue (US$ Million) & (2020-2025)
    • 7.14.5 Toxikon Recent Developments
  • 7.15 Goodwin Biotechnology
    • 7.15.1 Goodwin Biotechnology Profile
    • 7.15.2 Goodwin Biotechnology Main Business
    • 7.15.3 Goodwin Biotechnology Cell Banking Outsourcing Products, Services and Solutions
    • 7.15.4 Goodwin Biotechnology Cell Banking Outsourcing Revenue (US$ Million) & (2020-2025)
    • 7.15.5 Goodwin Biotechnology Recent Developments
  • 7.16 Texcell
    • 7.16.1 Texcell Profile
    • 7.16.2 Texcell Main Business
    • 7.16.3 Texcell Cell Banking Outsourcing Products, Services and Solutions
    • 7.16.4 Texcell Cell Banking Outsourcing Revenue (US$ Million) & (2020-2025)
    • 7.16.5 Texcell Recent Developments
  • 7.17 Cryo Stemcell
    • 7.17.1 Cryo Stemcell Profile
    • 7.17.2 Cryo Stemcell Main Business
    • 7.17.3 Cryo Stemcell Cell Banking Outsourcing Products, Services and Solutions
    • 7.17.4 Cryo Stemcell Cell Banking Outsourcing Revenue (US$ Million) & (2020-2025)
    • 7.17.5 Cryo Stemcell Recent Developments

8 Industry Chain Analysis

  • 8.1 Cell Banking Outsourcing Industrial Chain
  • 8.2 Cell Banking Outsourcing Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Cell Banking Outsourcing Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Cell Banking Outsourcing Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Cell Banking Outsourcing Market Trends
  • Table 2. Cell Banking Outsourcing Market Drivers & Opportunity
  • Table 3. Cell Banking Outsourcing Market Challenges
  • Table 4. Cell Banking Outsourcing Market Restraints
  • Table 5. Global Cell Banking Outsourcing Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Cell Banking Outsourcing Revenue Market Share by Company (2020-2025)
  • Table 7. Key Companies Cell Banking Outsourcing Manufacturing Base Distribution and Headquarters
  • Table 8. Key Companies Cell Banking Outsourcing Product Type
  • Table 9. Key Companies Time to Begin Mass Production of Cell Banking Outsourcing
  • Table 10. Global Cell Banking Outsourcing Companies Market Concentration Ratio (CR5 and HHI)
  • Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Banking Outsourcing as of 2024)
  • Table 12. Mergers & Acquisitions, Expansion Plans
  • Table 13. Global Cell Banking Outsourcing Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 14. Global Cell Banking Outsourcing Sales Value by Type (2020-2025) & (US$ Million)
  • Table 15. Global Cell Banking Outsourcing Sales Value by Type (2026-2031) & (US$ Million)
  • Table 16. Global Cell Banking Outsourcing Sales Market Share in Value by Type (2020-2025)
  • Table 17. Global Cell Banking Outsourcing Sales Market Share in Value by Type (2026-2031)
  • Table 18. Global Cell Banking Outsourcing Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 19. Global Cell Banking Outsourcing Sales Value by Application (2020-2025) & (US$ Million)
  • Table 20. Global Cell Banking Outsourcing Sales Value by Application (2026-2031) & (US$ Million)
  • Table 21. Global Cell Banking Outsourcing Sales Market Share in Value by Application (2020-2025)
  • Table 22. Global Cell Banking Outsourcing Sales Market Share in Value by Application (2026-2031)
  • Table 23. Global Cell Banking Outsourcing Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 24. Global Cell Banking Outsourcing Sales Value by Region (2020-2025) & (US$ Million)
  • Table 25. Global Cell Banking Outsourcing Sales Value by Region (2026-2031) & (US$ Million)
  • Table 26. Global Cell Banking Outsourcing Sales Value by Region (2020-2025) & (%)
  • Table 27. Global Cell Banking Outsourcing Sales Value by Region (2026-2031) & (%)
  • Table 28. Key Countries/Regions Cell Banking Outsourcing Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 29. Key Countries/Regions Cell Banking Outsourcing Sales Value, (2020-2025) & (US$ Million)
  • Table 30. Key Countries/Regions Cell Banking Outsourcing Sales Value, (2026-2031) & (US$ Million)
  • Table 31. SGS Life Sciences Basic Information List
  • Table 32. SGS Life Sciences Description and Business Overview
  • Table 33. SGS Life Sciences Cell Banking Outsourcing Products, Services and Solutions
  • Table 34. Revenue (US$ Million) in Cell Banking Outsourcing Business of SGS Life Sciences (2020-2025)
  • Table 35. SGS Life Sciences Recent Developments
  • Table 36. Lonza Basic Information List
  • Table 37. Lonza Description and Business Overview
  • Table 38. Lonza Cell Banking Outsourcing Products, Services and Solutions
  • Table 39. Revenue (US$ Million) in Cell Banking Outsourcing Business of Lonza (2020-2025)
  • Table 40. Lonza Recent Developments
  • Table 41. CCBC Basic Information List
  • Table 42. CCBC Description and Business Overview
  • Table 43. CCBC Cell Banking Outsourcing Products, Services and Solutions
  • Table 44. Revenue (US$ Million) in Cell Banking Outsourcing Business of CCBC (2020-2025)
  • Table 45. CCBC Recent Developments
  • Table 46. Vcanbio Basic Information List
  • Table 47. Vcanbio Description and Business Overview
  • Table 48. Vcanbio Cell Banking Outsourcing Products, Services and Solutions
  • Table 49. Revenue (US$ Million) in Cell Banking Outsourcing Business of Vcanbio (2020-2025)
  • Table 50. Vcanbio Recent Developments
  • Table 51. AMAG Pharmaceuticals Basic Information List
  • Table 52. AMAG Pharmaceuticals Description and Business Overview
  • Table 53. AMAG Pharmaceuticals Cell Banking Outsourcing Products, Services and Solutions
  • Table 54. Revenue (US$ Million) in Cell Banking Outsourcing Business of AMAG Pharmaceuticals (2020-2025)
  • Table 55. AMAG Pharmaceuticals Recent Developments
  • Table 56. ViaCord Basic Information List
  • Table 57. ViaCord Description and Business Overview
  • Table 58. ViaCord Cell Banking Outsourcing Products, Services and Solutions
  • Table 59. Revenue (US$ Million) in Cell Banking Outsourcing Business of ViaCord (2020-2025)
  • Table 60. ViaCord Recent Developments
  • Table 61. Thermo Fisher Basic Information List
  • Table 62. Thermo Fisher Description and Business Overview
  • Table 63. Thermo Fisher Cell Banking Outsourcing Products, Services and Solutions
  • Table 64. Revenue (US$ Million) in Cell Banking Outsourcing Business of Thermo Fisher (2020-2025)
  • Table 65. Thermo Fisher Recent Developments
  • Table 66. Wuxi Apptec Basic Information List
  • Table 67. Wuxi Apptec Description and Business Overview
  • Table 68. Wuxi Apptec Cell Banking Outsourcing Products, Services and Solutions
  • Table 69. Revenue (US$ Million) in Cell Banking Outsourcing Business of Wuxi Apptec (2020-2025)
  • Table 70. Wuxi Apptec Recent Developments
  • Table 71. CordLife Basic Information List
  • Table 72. CordLife Description and Business Overview
  • Table 73. CordLife Cell Banking Outsourcing Products, Services and Solutions
  • Table 74. Revenue (US$ Million) in Cell Banking Outsourcing Business of CordLife (2020-2025)
  • Table 75. CordLife Recent Developments
  • Table 76. Esperite Basic Information List
  • Table 77. Esperite Description and Business Overview
  • Table 78. Esperite Cell Banking Outsourcing Products, Services and Solutions
  • Table 79. Revenue (US$ Million) in Cell Banking Outsourcing Business of Esperite (2020-2025)
  • Table 80. Esperite Recent Developments
  • Table 81. Reliance Life Sciences Basic Information List
  • Table 82. Reliance Life Sciences Description and Business Overview
  • Table 83. Reliance Life Sciences Cell Banking Outsourcing Products, Services and Solutions
  • Table 84. Revenue (US$ Million) in Cell Banking Outsourcing Business of Reliance Life Sciences (2020-2025)
  • Table 85. Reliance Life Sciences Recent Developments
  • Table 86. Lifecell Basic Information List
  • Table 87. Lifecell Description and Business Overview
  • Table 88. Lifecell Cell Banking Outsourcing Products, Services and Solutions
  • Table 89. Revenue (US$ Million) in Cell Banking Outsourcing Business of Lifecell (2020-2025)
  • Table 90. Lifecell Recent Developments
  • Table 91. Cryo-Cell Basic Information List
  • Table 92. Cryo-Cell Description and Business Overview
  • Table 93. Cryo-Cell Cell Banking Outsourcing Products, Services and Solutions
  • Table 94. Revenue (US$ Million) in Cell Banking Outsourcing Business of Cryo-Cell (2020-2025)
  • Table 95. Cryo-Cell Recent Developments
  • Table 96. Toxikon Basic Information List
  • Table 97. Toxikon Description and Business Overview
  • Table 98. Toxikon Cell Banking Outsourcing Products, Services and Solutions
  • Table 99. Revenue (US$ Million) in Cell Banking Outsourcing Business of Toxikon (2020-2025)
  • Table 100. Toxikon Recent Developments
  • Table 101. Goodwin Biotechnology Basic Information List
  • Table 102. Goodwin Biotechnology Description and Business Overview
  • Table 103. Goodwin Biotechnology Cell Banking Outsourcing Products, Services and Solutions
  • Table 104. Revenue (US$ Million) in Cell Banking Outsourcing Business of Goodwin Biotechnology (2020-2025)
  • Table 105. Goodwin Biotechnology Recent Developments
  • Table 106. Texcell Basic Information List
  • Table 107. Texcell Description and Business Overview
  • Table 108. Texcell Cell Banking Outsourcing Products, Services and Solutions
  • Table 109. Revenue (US$ Million) in Cell Banking Outsourcing Business of Texcell (2020-2025)
  • Table 110. Texcell Recent Developments
  • Table 111. Cryo Stemcell Basic Information List
  • Table 112. Cryo Stemcell Description and Business Overview
  • Table 113. Cryo Stemcell Cell Banking Outsourcing Products, Services and Solutions
  • Table 114. Revenue (US$ Million) in Cell Banking Outsourcing Business of Cryo Stemcell (2020-2025)
  • Table 115. Cryo Stemcell Recent Developments
  • Table 116. Key Raw Materials Lists
  • Table 117. Raw Materials Key Suppliers Lists
  • Table 118. Cell Banking Outsourcing Downstream Customers
  • Table 119. Cell Banking Outsourcing Distributors List
  • Table 120. Research Programs/Design for This Report
  • Table 121. Key Data Information from Secondary Sources
  • Table 122. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Cell Banking Outsourcing Product Picture
  • Figure 2. Global Cell Banking Outsourcing Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Cell Banking Outsourcing Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Cell Banking Outsourcing Report Years Considered
  • Figure 5. Global Cell Banking Outsourcing Players Revenue Ranking (2024) & (US$ Million)
  • Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Cell Banking Outsourcing Revenue in 2024
  • Figure 7. Cell Banking Outsourcing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 8. Stem Cell Banking Picture
  • Figure 9. Non-stem Cell Banking Picture
  • Figure 10. Global Cell Banking Outsourcing Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 11. Global Cell Banking Outsourcing Sales Value Market Share by Type, 2024 & 2031
  • Figure 12. Product Picture of Cell Bank Storage
  • Figure 13. Product Picture of Bank Characterization and Testing
  • Figure 14. Product Picture of Cell Bank Preparation
  • Figure 15. Global Cell Banking Outsourcing Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 16. Global Cell Banking Outsourcing Sales Value Market Share by Application, 2024 & 2031
  • Figure 17. North America Cell Banking Outsourcing Sales Value (2020-2031) & (US$ Million)
  • Figure 18. North America Cell Banking Outsourcing Sales Value by Country (%), 2024 VS 2031
  • Figure 19. Europe Cell Banking Outsourcing Sales Value, (2020-2031) & (US$ Million)
  • Figure 20. Europe Cell Banking Outsourcing Sales Value by Country (%), 2024 VS 2031
  • Figure 21. Asia Pacific Cell Banking Outsourcing Sales Value, (2020-2031) & (US$ Million)
  • Figure 22. Asia Pacific Cell Banking Outsourcing Sales Value by Region (%), 2024 VS 2031
  • Figure 23. South America Cell Banking Outsourcing Sales Value, (2020-2031) & (US$ Million)
  • Figure 24. South America Cell Banking Outsourcing Sales Value by Country (%), 2024 VS 2031
  • Figure 25. Middle East & Africa Cell Banking Outsourcing Sales Value, (2020-2031) & (US$ Million)
  • Figure 26. Middle East & Africa Cell Banking Outsourcing Sales Value by Country (%), 2024 VS 2031
  • Figure 27. Key Countries/Regions Cell Banking Outsourcing Sales Value (%), (2020-2031)
  • Figure 28. United States Cell Banking Outsourcing Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. United States Cell Banking Outsourcing Sales Value by Type (%), 2024 VS 2031
  • Figure 30. United States Cell Banking Outsourcing Sales Value by Application (%), 2024 VS 2031
  • Figure 31. Europe Cell Banking Outsourcing Sales Value, (2020-2031) & (US$ Million)
  • Figure 32. Europe Cell Banking Outsourcing Sales Value by Type (%), 2024 VS 2031
  • Figure 33. Europe Cell Banking Outsourcing Sales Value by Application (%), 2024 VS 2031
  • Figure 34. China Cell Banking Outsourcing Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. China Cell Banking Outsourcing Sales Value by Type (%), 2024 VS 2031
  • Figure 36. China Cell Banking Outsourcing Sales Value by Application (%), 2024 VS 2031
  • Figure 37. Japan Cell Banking Outsourcing Sales Value, (2020-2031) & (US$ Million)
  • Figure 38. Japan Cell Banking Outsourcing Sales Value by Type (%), 2024 VS 2031
  • Figure 39. Japan Cell Banking Outsourcing Sales Value by Application (%), 2024 VS 2031
  • Figure 40. South Korea Cell Banking Outsourcing Sales Value, (2020-2031) & (US$ Million)
  • Figure 41. South Korea Cell Banking Outsourcing Sales Value by Type (%), 2024 VS 2031
  • Figure 42. South Korea Cell Banking Outsourcing Sales Value by Application (%), 2024 VS 2031
  • Figure 43. Southeast Asia Cell Banking Outsourcing Sales Value, (2020-2031) & (US$ Million)
  • Figure 44. Southeast Asia Cell Banking Outsourcing Sales Value by Type (%), 2024 VS 2031
  • Figure 45. Southeast Asia Cell Banking Outsourcing Sales Value by Application (%), 2024 VS 2031
  • Figure 46. India Cell Banking Outsourcing Sales Value, (2020-2031) & (US$ Million)
  • Figure 47. India Cell Banking Outsourcing Sales Value by Type (%), 2024 VS 2031
  • Figure 48. India Cell Banking Outsourcing Sales Value by Application (%), 2024 VS 2031
  • Figure 49. Cell Banking Outsourcing Industrial Chain
  • Figure 50. Cell Banking Outsourcing Manufacturing Cost Structure
  • Figure 51. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 52. Bottom-up and Top-down Approaches for This Report
  • Figure 53. Data Triangulation
  • Figure 54. Key Executives Interviewed